TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: SLE disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Functional magnetic resonance imaging (fMRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction Time of Vigilance Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Frequency of development of Lewy body diseases
Endpoint domain: Mortality/survival
Primary endpoint: Pain free response at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capillary CO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and frequency of treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Antibody Titer Responses to Vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to travel from home to Yale New Haven Hospital
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost to travel from home to Yale New Haven Hospital
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient Satisfaction with Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Binocular Distance Visual Acuity (LogMAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CLUE Overall Quality of Vision Using the Contact Lens User Experience (CLUE)TM Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in acceptability and feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: long-term efficacy of oral Ziprasidone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety, depression, stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: numerical rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: color analogue scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: faces rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of correct responses during word-generation tasks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Success Rate of Embolization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Side Effect Profile
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Molecular Remissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum voriconazole concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electromyography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dynamometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Presence or absence of deep invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Aneurysm wall strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualified rate of room disinfection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The number of colony-forming units (CFU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of Corneal Infiltrative Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidences of post operative behavioral changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to First Confirmed Worsening on the INCAT Disability Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in insulin requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in estrogen concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of participants needing ETT exchange
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of HIV testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Failure of restoration
Endpoint domain: Adverse events/effects
Primary endpoint: Acute Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence, Intensity and Relationship to Vaccination of Local and Systemic Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Clinically Relevant Abnormalities in the Laboratory Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for cortisol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: incidence of biopsy-proven acute allograft rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of PsA according to CASPAR-criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to disease progression from first-line treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to disease progression from maintenance treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerated Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of autologous bone marrow stem/progenitor cell infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Change in colorectal cancer knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in skin-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of subjects with persistent ALT elevations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Depressive symptoms measured by BDI II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in fecal short chain fatty acids (SCFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tibial nerve stimulation efficacy measured by LARS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in insulin secretion kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in disposition index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in insulinogenic index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Global Health Status Index (GHSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gait Balance Index (GBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who did not get pregnant
Endpoint domain: Mortality/survival
Primary endpoint: Raltitrexed plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of echocardiography-based PTTs and cardiac MRI-based PTTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of participants with a mature oocyte retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Sympathetic stimulation to BAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma concentration (Cmax) of PF-04965842
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from time zero to extrapolated infinite time (AUCinf) of PF-04965842
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time 0 to the time of the last quantifiable concentration (AUClast) of PF-04965842
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time profile from time 0-24hr (AUCtau) of PF-04965842
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in costal diaphragm activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in transdiaphragmatic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in mouth pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in abdominal movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wear of removable retainer per day (hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaching and maintaining meropenem PK-PD target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in side effects with consumption of alginate bread
Endpoint domain: Adverse events/effects
Primary endpoint: Change in VAS score: alert or sleepy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in VAS score: fine or nauseous
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in VAS score: full or starving
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in VAS score: not bloated or bloated
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in VAS score: not flatulent or flatulent
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in Binge Eating Scale (BES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: implant pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mutations and DNA alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freezing of gait score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Major Adverse Cardiovascular Events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in depressive symptom scores at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in depressive symptom scores at 8 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brain Calcitonin Gene-related Peptide (CGRP) Receptor Occupancy (RO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Telcagepant Plasma Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2 Year Local Control Rate
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants With Solicited Local Adverse Events Post Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Solicited Systemic Adverse Events Post Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Serious Adverse Events During Main Study
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients with a non removable recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity of Bedside Referral Tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to Antipsychotic Medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants With sPGA Response of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Participants With PASI 75 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Half-life of tau in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of new onset atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total exposure by area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS Sleep interruption
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Neuropathic Pain scale (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical cure without secondary intervention
Endpoint domain: Mortality/survival
Primary endpoint: tumor control probabilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Body Weight (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants With Reduction in Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Epworth Sleepiness Scale Score for Those With Daytime Sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Neuropsychiatric Inventory (NPI) Hallucinations Scale Score for Those With Hallucinations
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Circumference of Lower Leg/Foot at Greatest Point of Swelling for Pedal Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barratt Impulsiveness Scale Score for Those With Impulsive Behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with a loss of fewer than 15 letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cardiometabolic Biomarker - Total Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Cardiometabolic Biomarker - Log Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Who Maintained a Sustained Virologic Response (SVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Relapsed or Had a New Hepatitis C Virus (HCV) Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Persistence of Resistance-Associated Amino Acid Variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of AKI
Endpoint domain: Adverse events/effects
Primary endpoint: Total iodine excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: urinary iodine concentration (UIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Increments of medications used for sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress hyperglycemia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of subjects reported with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects reported with serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Achieving Sustained Clinical Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: White matter microstructure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grey matter volume changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive function (Neuropsychological test)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Accuracy of P2X7 for detection of uterine endometrial cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Left Ventricular Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Resting Left Ventricular Outflow Tract Gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in osteolytic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Mild Cognitive Impairment (MCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to septic shock resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive pregnancy test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Clinically-relevant bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Total radiation exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined severe morbidity & mortality
Endpoint domain: Mortality/survival
Primary endpoint: sodium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: acute 60-day toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: FEV1 AUC (0-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total nucleated cell yield of cord blood units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Simulator Sickness
Endpoint domain: Adverse events/effects
Primary endpoint: Level of Physical Fatigability
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Perceived Virtual Reality Experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic accuracy of cholangioscopy-directed biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adhesion
Endpoint domain: Adverse events/effects
Primary endpoint: Change in level of Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-perceived physical health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Independence in activities of daily living (ADLs)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Chemotherapy Symptom Management Knowledge Test (CSMKT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Terminal Hair Growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change of Urinary Incontinence Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent Change of Excess Voiding Frequency During Waking Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent Change of Frequency of Voids Awakening From Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percent Change of Frequency of Voids With Urgency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Visually estimated ejection fraction via telesonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quantitative ejection fraction by modified Simpson's method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pathological complete response (PCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of subjects who experience desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CTC, CEC or ctDNA incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: QTc Fridericia (QTcF) parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: hair loss and hair regrowth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Percent Area of Solution-related Corneal Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence Rate of Stroke and TIA
Endpoint domain: Mortality/survival
Primary endpoint: Intraocular Pressure (IOP) readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Age of COPD Patients at Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Charlson Comorbidity Index (CCI) at Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age of Patients Receiving First Maintenance Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Charlson Comorbidity Index (CCI) of Patients Receiving First Maintenance Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age of Patients Receiving Second Maintenance Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Charlson Comorbidity Index (CCI) of Patients Receiving Second Maintenance Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac anxiety questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in SAA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of fluids taken by the elderly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fluid deficit of the elderly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intraoperative bleeding assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cosmetic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ONSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes